
OpenAI launches ChatGPT Images 2.0 and desktop Codex as Stanford 2026 index shows surging AI adoption; Eli Lilly pays $115M for Insilico drug rights
Share your love
AI Tech News Today — Quick Roundup
Hello — this is Aurora with Isabelle.
Welcome to AI Tech News Today.
Date of this update: 2026-04-22T20:10:40Z
Today we have a fast roundup of the biggest AI headlines you need to know.
1) ChatGPT Images 2.0 launch
What’s new
- OpenAI released ChatGPT Images 2.0 — the new image model called gpt-image-two.
- Built for production-ready visual workflows (campaign assets, multilingual materials, structured design), not just creative sketches.
Key features
- Thinking mode for paid users (Plus, Pro, Business): searches the web, generates multiple images at once, and self-verifies before delivery.
- Quickly rose to #1 on the Arena.ai leaderboard with a 242-point lead.
Practical takeaway: you may soon get final, publishable marketing visuals from AI without a designer doing cleanup.
2) Codex becomes a full desktop agent
What changed
- Codex can now operate your entire computer: clicking, typing, opening apps, and scheduling future tasks.
- Adds image generation, a built-in browser for frontend previews, and session memory.
Adoption
- Already used by 3 million weekly developers; OpenAI calls it its most powerful agent as it builds a “super app” in public.
Practical takeaway: if you hate repetitive desktop tasks, Codex is trying to be your new — slightly bossy — assistant.
3) Live Translate heads to iPhone headphones
What’s happening
- Google brought Live Translate to iPhone users.
- Turns any headphones into a live interpreter across 70+ languages.
Highlights
- Expanded service to France, Germany, Japan, Spain, and the United Kingdom.
- Preserves speaker tone and cadence for more natural conversations.
4) Stanford 2026 AI Index — hard numbers
Top findings
- AI coding benchmark scores jumped from 60% to nearly 100% in one year.
- Organizational adoption: 88%.
- Generative AI population adoption: 53% — reached faster than the internet did.
- U.S. private AI investment (2025): $285.9 billion.
- Performance gap between U.S. and Chinese models has largely closed.
Practical takeaway: dramatic performance and adoption gains across the board.
5) Eli Lilly inks deal with Insilico Medicine
Deal details
- Eli Lilly secured exclusive worldwide rights to drugs discovered with Insilico Medicine’s Pharma.AI platform.
- Upfront payment: $115 million; additional payments tied to development, regulatory, and commercial milestones.
Practical takeaway: AI drug discovery is moving from lab demos toward real medicines for patients.
That’s our update for today.
Stay curious — keep an eye on how AI is shaping real products and real lives. We’ll be back with more news.














